Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr1018 Inhibitors

Olfr1018 is an olfactory receptor. Currently, there are no specific chemical inhibitors that have been developed or identified for olfactory receptors like Olfr1018. Olfactory receptors are part of the G protein-coupled receptor (GPCR) family. GPCR inhibitors encompass a wide range of chemicals that modulate the activity of G protein-coupled receptors, a large and diverse group of membrane receptors involved in various physiological processes. These receptors play key roles in the sensory system, including olfaction, as well as in neurotransmission, cardiovascular regulation, immune system modulation, and more. The inhibition or modulation of GPCRs can be achieved through various mechanisms. Some inhibitors act as antagonists, binding to the receptor and preventing its activation by endogenous ligands. Others work as inverse agonists, reducing the receptor's basal activity. Additionally, allosteric modulators can modulate receptor activity by binding to sites other than the ligand-binding site, influencing the receptor's response to its ligand.

The complexity of GPCR signaling is due to their ability to activate multiple downstream pathways. This includes the activation of various G proteins (Gs, Gi/o, Gq/11) and beta-arrestin pathways, leading to the modulation of second messengers like cAMP, calcium ions, and inositol phosphates. The chemicals listed above represent a spectrum of GPCR modulation strategies. They include antagonists for adrenergic, serotonergic, dopaminergic, histaminergic, and other receptors. Each of these chemicals has a unique interaction with GPCRs, reflecting the diversity of this receptor family. Their effects on GPCR signaling can have downstream impacts on a variety of physiological processes, potentially including the modulation of olfactory receptor activity, although such effects would be indirect and not specific to Olfr1018. The specific application of these compounds to modulate Olfr1018 or related olfactory receptors remains an area of ongoing research.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

A non-selective beta-adrenergic receptor antagonist that can indirectly influence GPCR signaling.

Ondansetron

99614-02-5sc-201127
sc-201127A
10 mg
50 mg
$80.00
$326.00
1
(0)

A serotonin 5-HT3 receptor antagonist, potentially affecting GPCR-mediated signal transduction.

Losartan

114798-26-4sc-353662
100 mg
$127.00
18
(1)

An angiotensin II receptor antagonist, modulating GPCR activity in cardiovascular systems.

Clozapine

5786-21-0sc-200402
sc-200402A
50 mg
500 mg
$68.00
$357.00
11
(1)

An atypical antipsychotic acting on various GPCRs, including dopaminergic and serotonergic receptors.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$50.00
$168.00
$520.00
2
(1)

An alpha-2 adrenergic receptor antagonist, influencing adrenergic GPCR pathways.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$122.00
$235.00
$520.00
$979.00
$1500.00
2
(1)

A non-selective beta-adrenergic antagonist with alpha-1 blocking activity, affecting GPCR signaling.

Cimetidine

51481-61-9sc-202996
sc-202996A
5 g
10 g
$62.00
$86.00
1
(1)

A histamine H2 receptor antagonist, modulating GPCR activity in gastric acid secretion.

(RS)-Atenolol

29122-68-7sc-204895
sc-204895A
1 g
10 g
$77.00
$408.00
1
(1)

A selective beta1-adrenergic receptor antagonist, indirectly influencing GPCR signaling pathways.

Ramipril

87333-19-5sc-205833
sc-205833A
sc-205833B
sc-205833C
sc-205833D
500 mg
1 g
2 g
5 g
10 g
$175.00
$240.00
$357.00
$719.00
$1229.00
1
(1)

An ACE inhibitor, indirectly affecting GPCR-mediated angiotensin II activity.

Haloperidol

52-86-8sc-507512
5 g
$190.00
(0)

A dopamine receptor antagonist, influencing dopaminergic GPCR systems.